Molbank (Jan 2023)

Cis-(3-benzyloxy-1,1-cyclobutanedicarboxylato κ<sup>2</sup>O,O′)bis(1-methyl-1<i>H</i>-pyrazole)platinum(II)

  • Anna S. Pavlova,
  • Daniil A. Buslaev,
  • Nataliya E. Borisova,
  • Victor V. Temnov,
  • Alexey A. Nazarov,
  • Tatyana A. Podrugina

DOI
https://doi.org/10.3390/M1564
Journal volume & issue
Vol. 2023, no. 1
p. M1564

Abstract

Read online

A huge variety of types of cancer makes it necessary to search for new effective drugs with a defined molecular target. Modification of substituents in ligands based on 3-hydroxy-1,1-cyclobutanedicarboxylic acid are one of the effective directions to design a better version of carboplatin. In the present study, we combined in one molecule a derivative of 3-hydroxycyclobutane-1,1-dicarboxylic acid and N-methylpyrazole as a carrier ligand. The antiproliferative of the novel complex Pt(II) was established for cell lines HCT116, MCF7, A549, and WI38 by means of a standard MTT colorimetric assay.

Keywords